找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer V; A. Goldhirsch Conference proceedings 1992 Springer-Verlag Berlin Heidelberg 1992 Breast cancer.Brust

[復(fù)制鏈接]
查看: 30717|回復(fù): 49
樓主
發(fā)表于 2025-3-21 17:47:58 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Endocrine Therapy of Breast Cancer V
編輯A. Goldhirsch
視頻videohttp://file.papertrans.cn/310/309739/309739.mp4
叢書名稱ESO Monographs
圖書封面Titlebook: Endocrine Therapy of Breast Cancer V;  A. Goldhirsch Conference proceedings 1992 Springer-Verlag Berlin Heidelberg 1992 Breast cancer.Brust
描述The European School of Oncology came into existence to respond to a need for informa- tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer- sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has
出版日期Conference proceedings 1992
關(guān)鍵詞Breast cancer; Brustkrebs; Endocrinology; Endokrinologie; Oncology; Onkologie; Post-Menopause; Postmenopaus
版次1
doihttps://doi.org/10.1007/978-3-642-77662-5
isbn_softcover978-3-642-77664-9
isbn_ebook978-3-642-77662-5
copyrightSpringer-Verlag Berlin Heidelberg 1992
The information of publication is updating

書目名稱Endocrine Therapy of Breast Cancer V影響因子(影響力)




書目名稱Endocrine Therapy of Breast Cancer V影響因子(影響力)學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開度




書目名稱Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V被引頻次




書目名稱Endocrine Therapy of Breast Cancer V被引頻次學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V年度引用




書目名稱Endocrine Therapy of Breast Cancer V年度引用學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V讀者反饋




書目名稱Endocrine Therapy of Breast Cancer V讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:52:35 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:18:45 | 只看該作者
地板
發(fā)表于 2025-3-22 05:21:03 | 只看該作者
5#
發(fā)表于 2025-3-22 10:16:14 | 只看該作者
The Multi-Drug Resistance Phenotype and its Reversal by Drugs (with Special Emphasis on Anti-OestroMulti-drug resistance (MDR) is an unfortunate term, since it implies resistance to a wide range of drugs. In fact the origin of the MDR phenomenon is the preclinical observation of cross resistance to a specific group of natural products, particularly anthracyclines, vinca alkaloids and epipodophyllotoxins.
6#
發(fā)表于 2025-3-22 13:30:26 | 只看該作者
7#
發(fā)表于 2025-3-22 18:21:46 | 只看該作者
8#
發(fā)表于 2025-3-22 23:18:23 | 只看該作者
https://doi.org/10.1007/978-94-011-4197-0nstrated in the haemopoietic system where the subclassification of leukaemias achieved in this way has led to a more objective approach to disease management and therapy. The success of the approach has depended on 3 major factors, namely, 1) the availability of specific immunological markers (monoc
9#
發(fā)表于 2025-3-23 02:39:00 | 只看該作者
10#
發(fā)表于 2025-3-23 06:52:59 | 只看該作者
Alisa Von Hagel,Daniela Mansbachduce the growth rate of some breast cancers was confirmed by Stanley Boyd [2] who found improvement in approximately one-third of patients. This result has been adequately supported throughout this century but it is now clear that any hormonal therapy will affect the growth rate of about one-third o
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 04:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
大同市| 丰县| 雷波县| 固阳县| 枣强县| 万州区| 汤原县| 申扎县| 安平县| 定州市| 南部县| 随州市| 仁寿县| 当阳市| 天门市| 湖北省| 沂源县| 兰考县| 靖江市| 池州市| 新昌县| 诸城市| 容城县| 仁化县| 仙居县| 四子王旗| 甘谷县| 芮城县| 八宿县| 金寨县| 东兰县| 化德县| 延川县| 远安县| 宝兴县| 合作市| 米泉市| 吉林市| 东莞市| 大姚县| 涿州市|